
@ShahidNShah
The health system's remote monitoring pilot programme for Medicaid patients with chronic diseases including hypertension and Type 2 diabetes is discussed by Ochsner Health Chief Digital Officer Dr. Denise Basow. Before the COVID-19 pandemic upended the healthcare industry and prompted more patients and providers to embrace virtual care, Louisiana-based Ochsner Health started its digital medicine initiative for tracking chronic diseases several years ago. In the midst of the pandemic, Ochsner started a trial programme aimed at remotely monitoring Medicaid recipients in Louisiana who had diseases like Type 2 diabetes and hypertension. The health system recently announced results from the first year of the pilot, saying that 59% of patients with poorly controlled diabetes were able to get the illness under control after 90 days and 50% of patients with uncontrolled hypertension.
Continue reading at mobihealthnews.com
Biotechnology, sometimes known as biotech, and its applications are developing at a dizzying pace, transforming industries like medical, agriculture, energy, and chemical and materials by developing …
Posted Nov 6, 2022 Biotech Healthcare
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm